Literature DB >> 2347598

Loss of antibody productivity during long-term cultivation of a hybridoma cell line in low serum and serum-free media.

S S Ozturk1, B O Palsson.   

Abstract

A murine hybridoma cell line (167.4G5.3) was adapted to grow in different serum concentrations over a six month period of time. Adaptation to low serum and to serum-free media improved growth rates, but at low serum (1.25%) the antibody productivity was diminished. Flow cytometric analysis showed the presence of two distinct cell populations with respect to intracellular and surface antibody concentrations. The loss in antibody productivity during adaptation could be attributed to the appearance of a low antibody-containing cell population. Cultures maintained at high serum concentrations did not loose the original high antibody productivity. In a separate experiment the kinetics of growth improvement and loss of antibody production were studied for adaptation from 5% to 1.25% serum-containing media. Over a time period of about four months, the population shifted completely from high-producing cells to low-producing ones in response to the 1.25% environment. A shift-up from 1.25% to 20% serum resulted in the elimination of the low producing population. These results suggest that, for the cell line used, serum-containing factors prevent the loss of antibody productivity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2347598     DOI: 10.1089/hyb.1990.9.167

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  3 in total

1.  Cultivation of the hybridoma cell line MN12 in a homogeneous continuous culture system: effect of culture age.

Authors:  J M Coco-Martin; D E Martens; T A van der Velden-de Groot; E C Beuvery
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

2.  Stability of a murine hybridoma is dependent on the clonal line and culture media.

Authors:  N Kessler; S Bertrand; M Aymard
Journal:  In Vitro Cell Dev Biol       Date:  1993-03

3.  Evaluation of a simple protein free medium that supports high levels of monoclonal antibody production.

Authors:  Y M Qi; P F Greenfield; S Reid
Journal:  Cytotechnology       Date:  1996-06       Impact factor: 2.058

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.